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Abstract: We investigated the effect of a 24-week energy-restricted intervention with low or high dairy
intake (LD or HD) on the metabolic profiles of urine, blood and feces in overweight/obese women by
NMR spectroscopy combined with ANOVA-simultaneous component analysis (ASCA). A significant
effect of dairy intake was found on the urine metabolome. HD intake increased urinary citrate,
creatinine and urea excretion, and decreased urinary excretion of trimethylamine-N-oxide (TMAO)
and hippurate relative to the LD intake, suggesting that HD intake was associated with alterations
in protein catabolism, energy metabolism and gut microbial activity. In addition, a significant time
effect on the blood metabolome was attributed to a decrease in blood lipid and lipoprotein levels
due to the energy restriction. For the fecal metabolome, a trend for a diet effect was found and
a series of metabolites, such as acetate, butyrate, propionate, malonate, cholesterol and glycerol
tended to be affected. Overall, even though these effects were not accompanied by a higher weight
loss, the present metabolomics data reveal that a high dairy intake is associated with endogenous
metabolic effects and effects on gut microbial activity that potentially impact body weight regulation
and health. Moreover, ASCA has a great potential for exploring the effect of intervention factors and
identifying altered metabolites in a multi-factorial metabolomic study.
Keywords: ASCA; body weight; dairy; metabolome; feces; short-chain fatty acid
1. Introduction
Obesity is a common and significant challenge to human health, not only because of a link with
chronic diseases [1], but also due to a global and rapidly growing prevalence [2]. Lifestyle factors
such as dietary patterns and physical activity play a key role in body weight maintenance [3,4]. Dairy
products are important components in the Western dietary pattern as a good source of protein, vitamins,
and minerals [5]. However, occasionally dairy consumption is proposed to have adverse effects on
human health due to a high content of fat, which has been proposed as a contributor for body weight
gain [6]. An evaluation based on 49 clinical trials by Lanou and Barnard [7] did not identify a conclusive
association between dairy consumption and weight changes. Louie et al. [8] published a systematic
review of 19 prospective cohort studies and reported that evidence is still not sufficient to conclude a
beneficial effect of dairy intake on body weight regulation. However, based on both epidemiological
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and intervention studies, the review suggested a negative relationship between dairy intake and weight
loss during energy restriction [9]. In addition, two meta-analyses have been published addressing the
role of dairy consumption in body weight regulation. Abargouei et al. [10] showed that dairy intake
without energy restriction may not be linked to a change in body weight, but a beneficial effect of dairy
products on body weight regulation was observed in the energy-restricted trial. Chen et al. [11] reported
that beneficial effects of dairy intake on body weight regulation and fat loss only existed in short-term
or energy-restricted studies, but not in long-term or non-energy-restricted studies. Hypotheses for
the potential underlying mechanisms explaining the link between intake of dairy components and
body weight regulation have been proposed; for instance, whey protein is associated with a positive
effect on body weight regulation due to its influence on satiety, thermogenesis, lipogenesis and body
composition [12]. Dietary calcium has been reported to enhance lipolysis [13], fat oxidation [14] and
fecal fat excretion [15]. Moreover, the gut microbiota stimulated by fermented dairy products [16] may
also be an important environmental factor to affect body weight by the modulation of energy and lipid
metabolism [17]. Recently, Nielsen et al. [18] reported that medium-chain fatty acids in milk can induce
the expression of angiopoietin-like 4 gene (ANGPLT4), which has been reported to inhibit lipoprotein
lipase and in turn regulate triglyceride metabolism [19]. To understand the link between dairy intake
and body weight regulation over long-term interventions, the introduction of metabolomics approaches
could contribute to elucidating the mechanisms underlying this association [20].
Therefore, in the present study, a nuclear magnetic resonance (NMR)-based metabolomics
approach was applied to investigate a 24-week energy-restricted intervention with low or high intake
of dairy products in overweight/obesity women, and thereby provide metabolic information for
further understanding the link between dairy intake and body weight regulation. NMR spectroscopy
is an attractive technique to provide the metabolite profiles of samples due to its advantages, including
simple sample preparation, high reproducibility and quick analysis of urine, blood and feces.
2. Material and Methods
2.1. Subjects
A total of 38 overweight or obese women (age = 18–60 years; BMI = 28–35 kg/m2) were randomly
assigned to a low-dairy (LD; n = 21) or high-dairy (HD; n = 17) intervention for 24 weeks with an
energy-restricted diet (500 kcal energy deficit/day). The 500 kcal energy deficit was set according
to the estimated energy requirement, based on body weight, sex, age and physical activity level
using the Nordic Nutrition Recommendations, and with a macronutrient composition of 30 energy
percentage (E%) fat, 52 E% carbohydrate and 18 E% protein. The LD diet consisted of a diet with
0–1 dairy products/day (<600 mg calcium/day) and the HD diet consisted of a diet with 4–5 dairy
products/day («1200 mg calcium/day). The two diets were matched for relative intakes of total fat,
carbohydrate, fiber and protein, and differed only in the sources due to the differences in dairy intakes.
The diets were not provided by the university but based on counseling. The detailed dietary intake
during energy-restricted intervention with HD or LD is provided in Table S1. At 0, 12 and 24 weeks
during the intervention period, urine, blood and feces were collected and frozen for NMR-based
metabolomics analysis. The present study was conducted according to the Helsinki II declaration
and all procedures followed were in accordance with the Danish National Committee on Health
Research Ethics. The study was registered on clinicaltrials.gov (NCT01199835). Written informed
consent was obtained from the participants after they had received oral and written information about
study procedures.
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2.2. Anthropometrics and Blood Pressure
Body weight (BW) was recorded by using a digital scale accurate to 0.1 kg (Lindeltronic 8000S,
Lindell’s, Malmo, Sweden). Waist and hip circumference (WC and HC) were measured with a
tape measure with a precision of 0.5 cm. Ventilated-hood indirect calorimetry (Jaeger Oxycon Pro®,
Cardinal Health Care GmbH, Hoechberg, Germany) was used to determine resting energy expenditure
(REE) and respiratory quotient (RQ). Body composition (FM, fat mass; FFM, fat free mass) was
measured by dual-energy X-ray absorptiometry (Lunar Prodigy DXA, Madison, WI, USA). Systolic
and diastolic blood pressure (SBP and DBP) were recorded by an automatic blood pressure monitor
(A & D Instruments LTD., Berkshire, UK). All measurements were repeated three times.
2.3. Biochemical Analysis
Fasting blood samples were collected for biochemical measurements. ABX Pentra 400 (Horiba
ABX, Montpellier, France) was used to determine glucose, total cholesterol (TC), low-density
lipoprotein cholesterol (LDLC), high-density lipoprotein cholesterol (HDLC), triglycerides (TG),
and free fatty acids (FAA). The serum insulin level was analyzed by a solid phase and two-site
chemiluminescent immunometric assay (Siemens Healthcare Diagnostics, Ballerup, Denmark) on an
IMMULITE 1000 Analyzer.
2.4. NMR Analysis
NMR spectra were acquired using a 600.13 MHz on a Bruker Avance 600 spectrometer with a
5-mm TXI probe (Bruker BioSpin, Rheinstetten, Germany). Urine samples were thawed, vortexed
and centrifuged at 10,000 g for 5 min at 4 ˝C, and then 500 µL of the supernatant was transferred to a
5 mm NMR tube and mixed with 100 µL of a 0.75 M phosphate buffer, which contained 0.5% sodium
trimethlysilyl propionate-d4 (TSP) in D2O. The 1H NMR spectra were recorded at 298 K by a standard
single-pulse experiment with pre-saturation of the water resonance (“zgpr”, Bruker BioSpin, Gmbh,
Rheinstetten, Germany). The main acquisition parameters included, data points: 32 K, relaxation
delay: 2 s, spectral width: 7288.63 Hz, and acquisition time: 2.25 s per scan. Plasma samples were also
thawed, vortexed and centrifuged at 10,000 g for 10 min at 4 ˝C and 400 µL supernatant was transferred
and mixed with 200 µL D2O in the NMR tube (5 mm). NMR spectra were acquired using “zgpr”
pulse sequence at 310 K. In addition, to reduce the line-broadening effect of macromolecules such as
lipoproteins, the “cpmg” pulse sequence, with a fixed receiver-gain value, a total spin-spin relaxation
delay of 100 ms and a spin-echo delay of 1 ms, was used to better acquire signals from low-molecular
weight metabolites. Lyophilized feces samples were first extracted by chloroform/methanol/water
method as described in our previous study [21] into two phases, water-soluble extract (WSE) and lipid
extract (LE). Then, the extract was dried and stored at ´80 ˝C until NMR analysis. The dried WSE was
dissolved in 550 µL D2O, 25 µL H2O and 25 µL D2O (0.05% TSP), and the dried LE was dissolved in
575 µL CDCl3 and 25 µL CDCl3 (0.05% TMS). The re-dissolved samples were vortexed thoroughly
and transferred immediately into NMR tubes. NMR spectra from both WSE and LE were analyzed by
using a standard “zgpr” pulse program at 298 K.
2.5. NMR Data Preprocessing
NMR spectra were preprocessed using auto-phase and auto-baseline corrections in the Topspin
3.0 software (Bruker BioSpin, Rheinstetten, Germany). The NMR spectra of blood were referenced to
the anomeric signal of α-glucose at 5.23 ppm, while the spectra of urine and feces were referenced to
TSP and TSM peaks at 0 ppm, respectively. The “icoshift” procedure was used to align NMR spectra
in MATLAB (R2012a, The Mathworks Inc., Natick, MA, USA) [22]. The spectral region from 0.0 to
10.0 ppm, excluding the residual water signals from 4.7 to 5.0 ppm for urine and blood samples,
the region between 0.5 and 9.5 ppm, excluding the water signals from 4.7 to 5.1 ppm for the fecal
water-soluble sample, and the region between 0.5 and 8.0 ppm, excluding the chloroform signals from
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7.1 to 7.3 ppm for the fecal lipid sample, were subdivided and integrated to binning data with a size of
0.01 ppm. Finally, for urine samples, the binned data were normalized to the total area of each NMR
spectrum in order to minimize the dilution effect.
2.6. Multivariate Data Analysis
ASCA method, which combines analysis of variance (ANOVA) and simultaneous component
analysis (SCA), was used in the present study. Two experimental factors, diet (LD and HD) and time
(0, 12 and 24 weeks), were included. The mean spectra were used to balance the number of samples
between different groups. According to ANOVA, the data matrix X (M ˆ N, where M is the number
of samples and N is the number of variables) was first split into matrices for diet and time (XD and
XT) and for interaction between the two factors (XDT), and a matrix with residuals (E), as described in
Equation (1):
X “ 1mT `XD `XT `XDT ` E (1)
where 1mT is the overall means.
SCA then decomposes each matrix, XD, XT and XDT, into a score matrix TD, TT and TDT, a loading
matrix PD, PT and PDT, respectively, and a residual matrix E as given in Equation (2):
X “ 1mT ` PDTTD ` PTTTT ` PDTTTDT ` E (2)
where 1mT is the overall means, PD (TD), PT (TT) and PDT (TDT) are the score (loading) matrices of
factor D, factor T and their interaction, respectively, and E is the residual matrix.
In this study, ASCA was performed on mean-centered and Pareto-scaled data using the ASCA
toolbox [23] under MATLAB environment (R2012a, The Mathworks Inc., Natick, MA, USA) and
validated using a permutation test.
2.7. Identification and Quantification of Metabolites
The NMR signals were carefully inspected for spectral alignment quality and excluded from
models if the peaks were poorly aligned. Then, the well-aligned signals were assigned as shown
in Table S2 based on our previous studies for urine and feces [21,24], and Psychogios et al. [25] for
blood. In addition, two-dimensional (2D) 13C-1H heteronuclear single quantum coherence (HSQC)
experiments were used on representative samples to confirm our tentative assignments. The relative
concentrations of identified metabolites were calculated according to their peak areas by reference to
the internal standard TSP or TMS concentration.
2.8. Statistical Analysis
Differences in baseline characteristics of the participants between LD and HD were analyzed with
unpaired t-tests using SAS 9.2 (SAS Institute Inc, Cary, NC, USA), and p value < 0.05 was considered a
statistically significant difference.
3. Results and Discussion
In recent years, NMR-based metabolomics has been used as a potential tool not only to identify
dietary biomarkers [26–28] but also to explore the metabolic effects of dietary interventions [29–31].
This study was conducted to investigate the changes in the human metabolome of urine, blood and
feces samples after intake of an energy-restricted LD or HD diet for 24 weeks. The identification of the
exact metabolic alterations associated with dairy products intake under energy restriction have large
implications because it would facilitate our understanding of the mechanisms by which dairy products
may assist in body weight regulation. There was no significant difference between treatment groups
at baseline (Table 1). Metabolomics data were analyzed using ASCA, which enables the inclusion
of underlying factors such as diet, time and their interaction, and facilitates the interpretation of the
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variation induced by different factors as compared with a conventional PCA model [32]. Furthermore,
through orthogonal projection of the samples onto the scores of the time and diet effects, we were
able to assess the magnitude of these effects [33]. Table 2 lists statistically significant values obtained
from 10,000 permutation tests in ASCA models, including the effects of diet, time and their interaction
(diet x time). The corresponding ASCA score and loading plots derived from significant models are
illustrated in Figures 1 and 2 for the diet and time effects on the urinary (p = 0.004) and blood (p = 0.003
for “zgpr” data; p = 0.0005 for “cpmg” data) metabolome, respectively, as well as Figure S1 for the
diet effects on the fecal metabolome, which tended to be significant (p = 0.09 for WSE; p = 0.06 for LE).
The ASCA model results revealed a significant diet effect on the urinary metabolome, but not on the
blood metabolome (Table 2). These results are in agreement with a previous study [24], where we
found that the diet effect is more evident in the urinary metabolome than in the blood metabolome.
In addition, Walsh et al. [34] likewise showed that urine samples are more sensitive in reflecting dietary
effects than plasma or saliva.
Table 1. Characteristics of the participants at baseline during energy-restricted intervention with high
or low dairy products a.
LD (n = 21) HD (n = 17) p
Age (year) 45.2 ˘ 2.9 41.3 ˘ 2.7 0.13
BMI (kg/m2) 30.4 ˘ 1.5 30.0 ˘ 1.6 0.68
FM (kg) 36.1 ˘ 2.2 36.3 ˘ 2.6 0.91
FFM (kg) 44.0 ˘ 2.3 47.2 ˘ 2.3 0.50
WC (cm) 96.3 ˘ 3.0 97.5 ˘ 3.0 0.66
HC (cm) 110.9 ˘ 2.5 109.5 ˘ 2.7 0.54
REE (kcal) 1389.0 ˘ 14.3 1447.8 ˘ 12.9 0.34
RQ 0.83 ˘ 0.17 0.83 ˘ 0.21 0.43
SBP (mmHg) 120.2 ˘ 3.7 119.1 ˘ 3.6 0.81
DBP (mmHg) 80.0 ˘ 3.3 79.5 ˘ 3.0 0.89
TC (mmol/L) 5.2 ˘ 1.0 5.2 ˘ 0.8 0.81
LDLC (mmol/L) 3.1 ˘ 0.9 3.1 ˘ 0.8 0.87
HDLC (mmol/L) 1.3 ˘ 0.4 1.4 ˘ 0.6 0.64
TG (mmol/L) 1.3 ˘ 0.8 1.2 ˘ 0.8 0.75
Plasma glucose (mmol/L) 5.6 ˘ 0.8 5.5 ˘ 0.6 0.73
Serum insulin (pmol/L) 52.7 ˘ 4.9 42.6 ˘ 5.8 0.28
FFA (µmol/L) 726.9 ˘ 15.9 619.4 ˘ 14.7 0.18
a Data are presented as mean ˘ SEM. Difference analysis was made by unpaired T-tests. LD, low dairy intake;
HD, high dairy intake; BMI, body mass index; FM, fat mass; FFM, fat free mass; WC, waist circumference;
HC, hip circumference; REE, resting energy expenditure; RQ, respiratory quotient; SBP, systolic blood
pressure; DBP, diastolic blood pressure; TC, total cholesterol; LDLC, low-density lipoprotein cholesterol;
HDLC, high-density lipoprotein cholesterol; TG, triglycerides; FFA, free fatty acids.
Table 2. p values of ASCA models by 10,000 permutations test.
Samples Diet Time Diet ˆ Time
Urine 0.004 0.66 0.25
Blood ZGPR a 0.39 0.003 0.96
Blood CPMG b 0.89 0.0005 0.95
Feces WSE c 0.09 0.52 0.98
Feces LE d 0.06 0.33 0.87
a NMR data were obtained using a “zgpr” pulse sequence; b NMR data were obtained using a “cpmg” pulse
sequence; c water-soluble extract; d lipid extract.
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urinary urea  excretion differently  as whey  intake  resulted  in  lower urea  excretion  [40],  and  also 
other studies have reported that protein source affects urinary urea excretion [41]. In addition, HD 
intake resulted in a higher urinary creatinine level relative to the LD intake. Together, these findings 
suggest that the HD diet regulates protein catabolism differently from the LD diet, which may help 
maintain  lean body mass better  than  the LD diet under dietary  energy  restriction,  since urinary 
Figure 1. ASCA score (A) and loading (B) plots of the diet effect from NMR-based urine metabolomics
in overweight/obese women who consumed the high and low dairy products. In the score plot,
the scores of each sample are also included. Assignments: citrate (2.54 and 2.68 ppm); creatinine
(3.05 and 4.06 ppm); TMAO (3.27 ppm); hippurate (3.97, 7.55, 7.64 and 7.84 ppm); urea (5.80 ppm).
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creatinine level has been validated as a marker of lean body mass [42]. Zemel et al. [13] also reported 
that a high dairy diet  reduced  lean body mass  loss  (p < 0.001) compared with  the  low dairy diet 
during energy restriction. Urea and creatinine are  two main markers of kidney  function  [43]. The 
impact  of  differences  in  urea  and  creatinine  excretion  on  renal  function  remains  unknown.  The 
metabolite TMAO originates from choline metabolism in the gut flora. Choline‐containing diets such 
as milk,  egg, meat  and  fish  can  increase  the  production  and  excretion  of  TMAO.  It  has  been 
proposed that TMAO raises the risk of cardiovascular disease (CVD) [44], but the link is a matter of 
dispute [45,46]. Intriguingly, a reduction in the urinary TMAO excretion after the HD consumption 
was observed in the present study, which indicates that the HD intake may regulate the gut flora to 
decrease TMAO production. In a metabolomics study comparing cheese and milk  intake, we also 
identified an effect of dairy  intake on urinary TMAO excretion [21]. In the present study, a  lower 
urinary hippurate was observed in the HD group than the LD group. Hippurate is synthesized as a 
glycine conjugate of benzoic acid, which  involves microbial metabolism and  finally excreted  into 
urine. Urinary hippurate has been reported as a marker of the gut microbial activity, but variations 
in hippurate excretion may also be attributed  to alterations  in glycine or CoA availability  [47].  In 
addition, urinary hippurate  level  is also  influenced by diet, gender, age, and disease  [47].  In  the 
present study,  the  lower urinary hippurate excretion observed  in  the HD group  likely reflects an 
effect on the gut microbiota’s activity in response to dairy intake. 
For the blood metabolome there was a significant effect of the energy restriction (time effect), 
which  could  be  ascribed  to  changes  in  the  lipid  and  lipoprotein  profile  as  shown  in  the ASCA 
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an effect of dairy intake on the blood metabolome was not detectable in the current study. A possible 
explanation  for  this  result  is  that  the energy  restriction had a substantially greater  impact on  the 
blood metabolome, masking any potential effect of the dairy intake on the blood metabolome. 
 
Figure 2. ASCA score and loading plots from NMR‐based blood metabolomics in overweight/obese 
women who consumed the high and low dairy products at 0, 12 and 24 weeks: (A) “zgpr” data; (B) 
“cpmg” data. In the score plot, the scores of each sample are also included. Assignments: LDL/VLDL 
(0.85 and 1.27 ppm); lipid (1.57, 2.01, 2.23, 3.21 and 5.30 ppm). 
Figure 2. ASCA score and loading plots from NMR-based blood metabolomics in overweight/obese
women who consumed the high and low dairy products at 0, 12 and 24 weeks: (A) “zgpr” data;
(B) “cpmg” data. In the score plot, the scores of each sample are also included. Assignments:
LDL/VLDL (0.85 and 1.27 ppm); lipid (1.57, 2.01, 2.23, 3.21 and 5.30 ppm).
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Figure 1 shows that the diet effect on the urinary metabolome can be ascribed to an increase in the
urinary excretion of citrate, creatinine and urea, and a decrease in hippurate and TMAO after intake of
the HD diet relative to the LD diet. Urinary citrate might originate directly from citrate-containing
foods, such as cranberry juice [35], tea [36], and grape juice [25]. Citric acid is also a main organic
acid in dairy products by Tormo and Izco [37]. Thus, an increase in urinary citrate level in the HD
group may originate directly from the HD intake. However, citrate is also endogenously synthesized
as a major tricarboxylic acid (TCA) cycle intermediate, and the higher urinary excretion of citrate
associated with HD consumption could also reflect that HD enhances the mitochondrial TCA cycle.
Such an endogenous metabolic effect is in agreement with a recent study on mice, which revealed that
whey protein diets increased the urinary excretion of TCA cycle intermediates including citrate and
thereby provided less substrate for lipogenesis, which resulted in decreased lipid accretion and body
weight [38]. Urea, a major product of protein catabolism, is synthesized from the urea cycle in liver
and excreted in the urine. Urinary urea has been validated as a biomarker of protein ingestion [39].
An increased urinary urea was observed after the HD intake but not after LD diet even though the
two diets were similar in protein content. In a study comparing whey, casein and skimmed milk
intake, it was also observed that protein source affected urinary urea excretion differently as whey
intake resulted in lower urea excretion [40], and also other studies have reported that protein source
affects urinary urea excretion [41]. In addition, HD intake resulted in a higher urinary creatinine
level relative to the LD intake. Together, these findings suggest that the HD diet regulates protein
catabolism differently from the LD diet, which may help maintain lean body mass better than the LD
diet under dietary energy restriction, since urinary creatinine level has been validated as a marker
of lean body mass [42]. Zemel et al. [13] also reported that a high dairy diet reduced lean body mass
loss (p < 0.001) compared with the low dairy diet during energy restriction. Urea and creatinine are
two main markers of kidney function [43]. The impact of differences in urea and creatinine excretion
on renal function remains unknown. The metabolite TMAO originates from choline metabolism in
the gut flora. Choline-containing diets such as milk, egg, meat and fish can increase the production
and excretion of TMAO. It has been proposed that TMAO raises the risk of cardiovascular disease
(CVD) [44], but the link is a matter of dispute [45,46]. Intriguingly, a reduction in the urinary TMAO
excretion after the HD consumption was observed in the present study, which indicates that the HD
intake may regulate the gut flora to decrease TMAO production. In a metabolomics study comparing
cheese and milk intake, we also identified an effect of dairy intake on urinary TMAO excretion [21].
In the present study, a lower urinary hippurate was observed in the HD group than the LD group.
Hippurate is synthesized as a glycine conjugate of benzoic acid, which involves microbial metabolism
and finally excreted into urine. Urinary hippurate has been reported as a marker of the gut microbial
activity, but variations in hippurate excretion may also be attributed to alterations in glycine or
CoA availability [47]. In addition, urinary hippurate level is also influenced by diet, gender, age,
and disease [47]. In the present study, the lower urinary hippurate excretion observed in the HD group
likely reflects an effect on the gut microbiota’s activity in response to dairy intake.
For the blood metabolome there was a significant effect of the energy restriction (time effect),
which could be ascribed to changes in the lipid and lipoprotein profile as shown in the ASCA loading
plots in Figure 2. These findings corroborate a recent metabolomics study conducted during a 6-week
calorie restriction [48], and propose beneficial effects of weight loss on CVD risk. However, an effect of
dairy intake on the blood metabolome was not detectable in the current study. A possible explanation
for this result is that the energy restriction had a substantially greater impact on the blood metabolome,
masking any potential effect of the dairy intake on the blood metabolome.
In addition, the ASCA results indicated that dairy intake affected microbial-related metabolites in
the fecal metabolome, including SCFAs (acetate, butyrate and propionate) and malonate (Figure S1).
However, the diet effect of this ASCA model was not significant (Table 2), which may be attributed
to the energy restriction in the study, as we found that the levels of fecal SCFAs and malonate
were significantly altered after milk or cheese consumption in a previous study without energy
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restriction [21]. St-Onge et al. [16] also reported that fermented dairy products can increase the
amount of gut microbiota and in turn produce more SCFAs. Moreover, dairy intake also affected
cholesterol, glycerol and lipid levels in feces as shown in Figure S1, which may also be regulated
by gut microbiota-derived SCFAs. For instance, acetate is a precursor of cholesterol synthesis,
whereas propionate and butyrate may inhibit cholesterol formation and reduce fat absorption [49,50].
Another plausible explanation for the higher fecal fat excretion with the HD diet could be that dairy
calcium binds fat, which is then excreted in the feces [15]. Thus, lipid and microbial metabolism appear
to be affected by dairy intake.
4. Conclusions
In the present study, using ASCA to separate diet and time effects and thereby reduce complexity
of metabolomics data, we explored the effect of dairy intake on the human metabolome after a
long-term energy restriction intervention. The ASCA model showed a significant diet effect on the
urinary metabolome, a significant time effect on the blood metabolome and a borderline diet effect
on the fecal metabolome. We found that the energy restriction affected blood lipid profile, implying
beneficial effects on CVD risk. The dairy-induced changes reflected in the metabolome involved protein
catabolism, endogenous energy, lipid and gut microbial metabolism, which likely impact maintenance
of lean body mass, fat deposition and gut health. Consequently, the present study, which has high
translational value because of the long duration of the intervention period, has provided new insight
into metabolic effects associated with dairy intake. However, further studies are needed to corroborate
the detailed relationship between the specific metabolic effects identified, body weight regulation and
human health.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/8/3/108/s1,
Figure S1: ASCA score and loading plots from NMR-based fecal metabolomics in overweight/obesity women
consumed the high (#) and low (P) dairy products: (A) score plots based on chloroform soluble extraction;
(B) score plots based on water soluble extraction. Assignments: acetate (1.92 ppm); propionate (1.05 and 2.16 ppm);
butyrate (0.90, 1.56 and 2.20 ppm); malonate (3.11 ppm); glycerol (3.56, 3.65 and 3.77 ppm); cholesterol (0.91 and
1.04 ppm); lipid (0.80, 1.22, 1.55 and 2.27 ppm), Table S1: Dietary intake during energy-restricted intervention
with high or low dairy products, Table S2: Assignment of metabolites in 1H NMR spectra of urine, blood and
feces in overweight and obesity women.
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